Medtech was not on Jesper Kimer’s radar when pioneering mobile phone company Nokia took him into its graduate program. A few career turns later, having fulfilled a desire to become an entrepreneur, his expertise and interests met in the middle when he co-founded thyroid disorder home monitoring start-up, HEI Therapeutics.
The case for home-monitoring of hypothyroidism is not obvious; not to everyone, that is. Jesper Kimer, head of the Danish start-up HEI Therapeutics, says as much.
“The technology is complex to succeed in. And because thyroid medication is a generic drug, pharma doesn’t have a big...